Notes And Other Explanatory Information [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166135

Concept 2023-01-01 to
2023-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]
3. ESTIMATIONS COMPTABLES ET
Disclosure of auditors' remuneration [text block]
30. HONORAIRES D’AUDIT
Disclosure of authorisation of financial statements [text block]
La publication des états financiers consolidés a été
Disclosure of basis of preparation of financial statements [text block]
2
Disclosure of borrowings [text block]
15. EMPRUNTS ET AUTRES PASSIFS
Disclosure of cash and cash equivalents [text block]
13. TRÉSORERIE ET ÉQUIVALENTS DE
Disclosure of commitments [text block]
27. ENGAGEMENTS ET PASSIFS
Disclosure of commitments and contingent liabilities [text block]
26. CONTINGENCES
Disclosure of cost of sales [text block]
19. CHARGES PAR NATURE
Disclosure of credit risk [text block]
4.5 RISQUE DE CRÉDIT
Disclosure of deferred taxes [text block]
17. IMPÔTS DIFFÉRÉS
Disclosure of depreciation and amortisation expense [text block]
(en milliers d’euros)
Disclosure of earnings per share [text block]
24. RÉSULTAT PAR ACTION
Disclosure of effect of changes in foreign exchange rates [text block]
4
Disclosure of entity's operating segments [text block]
5. SECTEURS OPÉRATIONNELS
Disclosure of events after reporting period [text block]
29. ÉVÉNEMENT POSTÉRIEURS À LA
Disclosure of financial instruments [text block]
4. INSTRUMENTS FINANCIERS ET GESTION DES RISQUES FINANCIERS
Disclosure of financial instruments designated at fair value through profit or loss [text block]
4.1 APERÇU DES INSTRUMENTS FINANCIERS
Disclosure of financial risk management [text block]
4
Disclosure of general information about financial statements [text block]
1. INFORMATIONS GÉNÉRALES
Disclosure of going concern [text block]
3
Disclosure of government grants [text block]
11. CRÉANCES CLIENTS ET AUTRES
Disclosure of impairment of assets [text block]
7. IMMOBILISATIONS INCORPORELLES
Disclosure of income tax [text block]
23. CHARGE D’IMPÔT SUR LE RESULTAT
Disclosure of information about employees [text block]
20. CHARGES AU TITRE DES AVANTAGES
Disclosure of information about key management personnel [text block]
28
Disclosure of interest income [text block]
22. RÉSULTAT FINANCIER
Disclosure of investments accounted for using equity method [text block]
9. PARTICIPATIONS MISES EN
Disclosure of investments other than investments accounted for using equity method [text block]
10. AUTRES ACTIFS FINANCIERS, Y
Disclosure of issued capital [text block]
Capital social
Disclosure of leases [text block]
8. ACTIFS AU TITRE DE DROITS D’UTILISATION
Disclosure of liquidity risk [text block]
5
Disclosure of loans and advances to customers [text block]
3
Disclosure of market risk [text block]
5
Disclosure of material accounting policy information [text block]
2. RÉSUMÉ DES PRINCIPALES MÉTHODES
Disclosure of objectives, policies and processes for managing capital [text block]
14
Disclosure of other liabilities [text block]
15
Disclosure of other operating expense [text block]
Les charges par nature représentent une alternative
Disclosure of other operating income [text block]
21. AUTRES REVENUS D’EXPLOITATION
Disclosure of prepayments and other assets [text block]
12. AVANCES
Disclosure of related party [text block]
28. TRANSACTIONS ENTRE PARTIES LIÉES
Disclosure of reserves within equity [text block]
Autres réserves
Disclosure of revenue [text block]
18. REVENUS
Disclosure of information about separate financial statements [text block]
État de la situation financière
Disclosure of share capital, reserves and other equity interest [text block]
14. CAPITAL
Disclosure of share-based payment arrangements [text block]
25. PAIEMENTS FONDÉS SUR DES
Disclosure of subsidiaries [text block]
6. LISTE DES SOCIETES CONSOLIDÉES AU 31 DÉCEMBRE 2023
Disclosure of tax receivables and payables [text block]
23
Disclosure of trade and other payables [text block]
16. DETTES FOURNISSEURS ET AUTRES

Talk to a Data Expert

Have a question? We'll get back to you promptly.